SCHEMBL21863404

SCHEMBL21863404

Cc1cncc(-n2cnnc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 3/20 0.40
CHRNB4 P30926 3/20 0.40
CHRNA3 P32297 3/20 0.40
CHRNA4 P43681 3/20 0.40
HCAR2 Q8TDS4 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
RXRA P19793 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
NOTUM Q6P988 1/20 0.35
ATM Q13315 1/20 0.33
CYP11B1 P15538 2/20 0.33
CYP11B2 P19099 2/20 0.33
CYP2A6 P11509 4/20 0.32
CYP2E1 P05181 1/20 0.31
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12369610 0.78 CHRNB2 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4HCAR2
SCHEMBL21848980 0.74 CYP11B2 (0.35) CYP1A2CYP2C9CYP11B1CYP11B2
SCHEMBL21233113 0.72 CYP2E1 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4HCAR2
SCHEMBL29176201 0.72 CYP1A2 (0.30) CYP1A2CYP2C9
SCHEMBL30811735 0.72 CYP1A2 (0.30) CYP1A2CYP2C9
SCHEMBL17858623 0.72 NOTUM (0.67) RXRAGRIN1GRIN2BNOTUM
SCHEMBL22952499 0.71 CYP2E1 (0.37) CHRNB2CHRNB4CHRNA3CHRNA4RXRA
SCHEMBL20153304 0.70 CHRNB2 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4HCAR2
SCHEMBL10053917 0.70 HSP90AA1 (0.47) CYP1A2CYP2C9GABRG2GABRB3GABRA5
SCHEMBL14022007 0.70 CHRNB2 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020065614-A1 MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-04-02 WO disclosed